KETANNABIDIOL

Serial Number 88070776
606

Registration Progress

Application Filed
Dec 20, 2018
Under Examination
May 31, 2022
Approved for Publication
Apr 5, 2022
Published for Opposition
Apr 5, 2022
Registered

Trademark Image

KETANNABIDIOL

Basic Information

Serial Number
88070776
Filing Date
December 20, 2018
Published for Opposition
April 5, 2022
Abandonment Date
January 2, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 2, 2023
Classes
005

Rights Holder

Axcess Global Sciences, LLC

16
Address
Suite 102
2040 East Murray Holladay Road
Salt Lake City, UT 84117

Ownership History

Axcess Global Sciences, LLC

Original Applicant
16
Salt Lake City, UT

Axcess Global Sciences, LLC

Owner at Publication
16
Salt Lake City, UT

Legal Representation

Attorney
John Guynn

USPTO Deadlines

All Deadlines Cleared

All 12 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

47 events
Date Code Type Description Documents
Jan 3, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jan 2, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 31, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 5, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 5, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 1, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 1, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 1, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 1, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 1, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 8, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 27, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 27, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 27, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 27, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 16, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 19, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 13, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 12, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jul 12, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 12, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
Jan 12, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 12, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Dec 28, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 28, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 28, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 27, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 27, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 27, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 9, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 8, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 8, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 30, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 30, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 30, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 8, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 8, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 10, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 10, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 10, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 1, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 16, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 16, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 11, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Dietary and nutritional supplements featuring beta-hydroxybutyrate esters, acetoacetate, acetoacetate esters, and precursors thereof such as 1,3-butanediol, medium chain triglycerides, medium chain fatty acids, and medium chain fatty acid esters, in combination with hemp-derived cannabinoids, namely, cannabidiol and tetrahydrocannabinol; all of the foregoing goods contain hemp and not more than naturally occurring trace amounts of cannabidiol (CBD) that are solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005